BriaCell Therapeutics (BCTX) Institutional Ownership $3.75 -0.63 (-14.38%) Closing price 04/15/2025 03:59 PM EasternExtended Trading$4.99 +1.24 (+32.96%) As of 09:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BriaCell Therapeutics (NASDAQ:BCTX)CurrentInstitutional OwnershipPercentage15.42%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$3.76MNumber ofInstitutional Sellers(last 12 months)0 Get BCTX Insider Trade Alerts Want to know when executives and insiders are buying or selling BriaCell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BCTX Institutional Buying and Selling by Quarter Remove Ads BriaCell Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Cantor Fitzgerald L. P.56,000$32K0.0%N/A1.900% 2/11/2025Virtu Financial LLC48,663$27K0.0%N/A1.650% 1/30/2025Vontobel Holding Ltd.110,000$62K0.0%+37.5%0.249% 10/16/2024Vontobel Holding Ltd.80,000$99K0.0%N/A0.438% 4/29/2024Onyx Bridge Wealth Group LLC50,000$143K0.0%+66.7%0.313% 4/27/2024K.J. Harrison & Partners Inc87,044$249K0.0%+7.8%0.545% 2/14/2024Wasatch Advisors LP267,410$1.56M0.0%-48.0%1.673% 2/12/2024Redmond Asset Management LLC133,569$781K0.3%-3.1%0.836% 2/6/2024National Bank of Canada FI7,500$40K0.0%+200.0%0.047% 2/2/2024K.J. Harrison & Partners Inc80,715$476K0.1%+22.1%0.505% Get the Latest News and Ratings for BCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024Onyx Bridge Wealth Group LLC30,000$176K0.0%N/A0.188% 11/13/2023K2 Principal Fund L.P.24,969$156K0.0%N/A0.156% 10/31/2023K.J. Harrison & Partners Inc66,090$411K0.1%+90.8%0.414% 10/25/2023Concord Wealth Partners10,775$67K0.0%-29.5%0.067% 8/11/2023Natixis90,250$579K0.0%N/A0.565% 8/8/2023Wasatch Advisors LP612,088$3.93M0.0%-0.6%3.830% 8/8/2023Concord Wealth Partners15,275$98K0.0%-14.1%0.096% 8/2/2023Bank of Montreal Can34,629$217K0.0%N/A0.217% 7/21/2023K.J. Harrison & Partners Inc34,640$217K0.0%-67.3%0.217% 4/25/2023K.J. Harrison & Partners Inc105,933$785K0.2%-75.2%0.683% 2/7/2023Lynwood Capital Management Inc.1,530,000$6.69M8.0%+27.7%9.860% 1/25/2023K.J. Harrison & Partners Inc427,583$2.52B0.5%-10.9%2.755% 11/8/2022Apollon Wealth Management LLC17,900$101K0.0%+12.6%0.115% 11/7/2022Virtu Financial LLC48,347$272K0.0%+362.5%0.312% 10/25/2022Lynwood Capital Management Inc.1,198,000$6.73M7.4%+94.8%7.720% 10/21/2022K.J. Harrison & Partners Inc479,838$2.75M1.0%-70.1%3.092% 8/11/2022Apollon Wealth Management LLC15,900$92K0.0%+14.4%0.102% 8/2/2022Lynwood Capital Management Inc.615,000$3.55M4.0%-18.0%3.963% 7/27/2022K.J. Harrison & Partners Inc1,607,027$9.19M2.5%+18.9%10.355% 5/5/2022Lynwood Capital Management Inc.750,000$7.61M8.2%-4.5%4.908% 4/21/2022K.J. Harrison & Partners Inc1,351,782$13.75M2.2%N/A8.847% 4/20/2022Concord Wealth Partners16,775$170K0.0%+31.3%0.110% 2/9/2022 Insight Advisors LLC PA16,900$140K0.0%N/A0.106% 2/3/2022Total Clarity Wealth Management Inc.15,818$131K0.1%+38.5%0.099% 1/21/2022Concord Wealth Partners12,775$106K0.0%N/A0.080% 11/16/2021Two Sigma Investments LP62,139$503K0.0%N/A0.404% 11/16/2021Voloridge Investment Management LLC156,946$1.27M0.0%N/A1.021% 10/22/2021Redmond Asset Management LLC136,593$1.11M0.3%+3.7%0.890% 10/21/2021Total Clarity Wealth Management Inc.11,425$93K0.0%N/A0.074% 10/19/2021Belvedere Trading LLC13,608$107K0.0%N/A0.089% What to do with your collapsing portfolio… (Ad)There might be only one way to save your retirement in this volatile time. After watching investors lose $6 trillion in market cap in a matter of DAYS... And after seeing businesses bleeding dry as trade tensions spiral out of control... What the acclaimed “Market Wizard” Larry Benedict — who beat the market by 103% during the 2008 crash — is about to reveal could not only save your retirement from Trump's tariffs…Click here to access this emergency briefing BEFORE the next tariff announcement...10/13/2021FNY Investment Advisers LLC4,687$37K0.0%N/A0.031% 10/13/2021Gofen & Glossberg LLC IL10,000$81K0.0%N/A0.065% 8/25/2021Marshall Wace LLP63,226$337K0.0%N/A0.414% 8/17/2021Armistice Capital LLC570,343$3.04M0.1%N/A3.735% 8/16/2021Sabby Management LLC196,033$1.05M0.1%+22.4%1.284% 8/16/2021Marshall Wace LLP63,226$337K0.0%N/A0.414% 8/13/2021Altium Capital Management LP800,295$4.27M1.0%N/A5.241% 8/13/2021Murchinson Ltd.250,000$1.33M0.5%N/A1.637% 8/12/2021MMCAP International Inc. SPC400,000$2.13M0.1%N/A2.620% 8/12/2021Kepos Capital LP500,000$2.67M0.2%N/A3.274% 8/12/2021Eqis Capital Management Inc.21,182$113K0.0%+29.6%0.139% 8/11/2021CVI Holdings LLC320,800$1.71M0.1%N/A2.101% 5/19/2021Virtu Financial LLC15,121$58K0.0%N/A0.260% 5/14/2021Eqis Capital Management Inc.16,339$63K0.0%N/A0.281% 5/6/2021Redmond Asset Management LLC131,731$508K0.2%N/A2.266% (Data available from 1/1/2016 forward)Remove Ads BCTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BCTX shares? During the previous two years, 12 institutional investors and hedge funds held shares of BriaCell Therapeutics. The most heavily invested institutionals were Wasatch Advisors LP ($1.56M), Redmond Asset Management LLC ($781K), Natixis ($579K), K.J. Harrison & Partners Inc ($249K), Bank of Montreal Can ($217K), K2 Principal Fund L.P. ($156K), and Onyx Bridge Wealth Group LLC ($143K).Learn more on BCTX's institutional investors. What percentage of BriaCell Therapeutics stock is owned by institutional investors? 15.42% of BriaCell Therapeutics stock is owned by institutional investors. Learn more on BCTX's institutional investor holdings. Which institutional investors have been buying BriaCell Therapeutics stock? Of the 9 institutional investors that purchased BriaCell Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vontobel Holding Ltd. ($110K), Natixis ($90.25K), Cantor Fitzgerald L. P. ($56K), K.J. Harrison & Partners Inc ($52.40K), Onyx Bridge Wealth Group LLC ($50K), Virtu Financial LLC ($48.66K), and Bank of Montreal Can ($34.63K). How much institutional buying is happening at BriaCell Therapeutics? Institutional investors have bought a total of 471,915 shares in the last 24 months. This purchase volume represents approximately $25.43M in transactions. Which BriaCell Therapeutics major shareholders have been selling company stock? The following institutional investors have sold BriaCell Therapeutics stock in the last 24 months: K.J. Harrison & Partners Inc ($392.94K), Wasatch Advisors LP ($250.34K), Concord Wealth Partners ($7K), and Redmond Asset Management LLC ($4.27K). How much institutional selling is happening at BriaCell Therapeutics? Institutional investors have sold a total of 654,554 shares in the last 24 months. This volume of shares sold represents approximately $65.85M in transactions. Related Companies SAVA Major Shareholders VTGN Major Shareholders JSPR Major Shareholders IVVD Major Shareholders INZY Major Shareholders CLSD Major Shareholders VTVT Major Shareholders BMEA Major Shareholders ACHL Major Shareholders ADAP Major Shareholders This page (NASDAQ:BCTX) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredMusk's panic move: What the world's richest man fears is comingWhether you have modest savings of $10,000 or substantial wealth of $10 million, this information could determ...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BCTX Stock Free BCTX Stock Alerts